Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “monoclonal”

203 pharma patents match "monoclonal" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 203
Index total 30,257
Page 5 / 9

Quick answer

This filtered view shows 203 pharmaceutical patents matching "monoclonal" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

203 results for “monoclonal” · 30,257 patents in full index Clear search

  1. US 9555112

    Monoclonal antibodies against HER2 epitope and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  2. US 9534041

    Monoclonal antibodies that neutralize a norovirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted

  3. US 9513287

    High affinity monoclonal antibodies for detection of shiga toxin 2

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted

  4. US 9499608

    Bispecific monoclonal antibody therapeutics against West Nile virus with improved CNS penetration

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  5. US 9441050

    High-affinity monoclonal anti-prion antibodies

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  6. US 9409994

    High-affinity monoclonal antibodies to glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted

  7. US 9409992

    Mesothelin domain-specific monoclonal antibodies and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted

  8. US 9394364

    Human monoclonal antibodies specific for glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  9. US 2016185873

    MONOCLONAL ANTIBODIES FOR TREATMENT OF CANCER

    GANYMED PHARMACEUTICALS AG [DE] · Granted Jun 30, 2016 · Expires Jun 25, 2036

    granted

  10. US 9371375

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted

  11. US 9310368

    High affinity monoclonal antibodies for detection of Shiga toxin 2 (STX2)

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  12. US 9303087

    Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  13. US 9279019

    Human monoclonal antibodies specific for CD22

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

  14. US 9273121

    Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  15. US 9273124

    Monoclonal antibodies that react with the capsule of Bacillus anthracis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  16. US 9273136

    Fully human anti-human NKG2D monoclonal antibodies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  17. US 9206257

    Human monoclonal antibodies specific for glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  18. US 9181330

    Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

    The Regents of the University of California · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  19. US 9169326

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  20. US 9150644

    Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  21. US 9127056

    Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  22. US 9097713

    Monoclonal antibodies against glycoprotein of Ebola sudan boniface virus

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF USAMRMC · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  23. US 9034588

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted May 19, 2015 · Expires May 14, 2035

    granted

  24. US 8999336

    Monoclonal antibodies against Orthopoxviruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.